Log In
Print
BCIQ
Print
Print this Print this
 

tofogliflozin (CSG452) (formerly R7201, RG7201)

  Manage Alerts
Collapse Summary General Information
Company Chugai Pharmaceutical Co. Ltd.
DescriptionSodium-glucose transporter 2 (SGLT2) inhibitor
Molecular Target Sodium-glucose cotransporter 2 (SGLT2)
Mechanism of ActionSodium-glucose cotransporter 2 (SGLT2) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationDiabetes
Indication DetailsTreat Type II diabetes
Regulatory Designation

Partner

Kowa Co. Ltd.; Sanofi


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today